Michelle M. J. Mens

Michelle M. J. Mens

Auto-generated profile, based on publicly available information

Michelle M. J. Mens

Department of Social and Behavioral Sciences, Harvard T H Chan School of Public Health, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Stroke
Verified
Journal Article
Closed access
PDF file
MMMichelle M.J. Mens
Michelle M.J. Mens
AHAlis Heshmatollah
Alis Heshmatollah
LFLana Fani
Lana Fani
MIM. Arfan Ikram
M. Arfan Ikram
MIM. Kamran Ikram
M. Kamran Ikram
MGMohsen Ghanbari
Mohsen Ghanbari
Background and Purpose: MicroRNAs (miRNAs) are post-transcriptionally regulators of gene expression that can be released extracellularly upon pathophysiological processes. By complementary binding of target transcripts, miRNAs can modulate the expression of an abundance of genes. Increasing evidence recognize miRNAs as promising biomarkers for complex traits, including cardiovascular disease and stroke. We conducted a longitudinal study to determine the association between circulatory miRNAs and incident stroke in a population-based setting. Methods: Next-generation sequencing was used to measure expression levels of 2083 miRNAs in plasma samples, collected between 2002 and 2005, from 1914 stroke-free participants of the Rotterdam Study. Participants were assessed for incident stroke through continuous monitoring of medical records until January 1, 2016. Cox proportional hazards regression models adjusted for age, sex, and vascular risk factors were used to investigate the association between the levels of 591 miRNAs well-expressed in plasma and incident stroke. Furthermore, stroke subtype analysis was performed to assess the link between identified miRNAs and ischemic, hemorrhagic, and unspecified stroke. Subsequently, post hoc analyses were conducted to gain insight into the association between putative target genes of miRNAs and stroke. Results: Of 1914 participants (mean age 71.5 years ±7.6; 57.7% women), 138 were diagnosed with incident stroke during a mean follow-up of 9.7±3.2 years. After adjusting for potential confounders, we found plasma levels of 3 miRNAs to be associated with incident stroke (false discovery rate-adjusted P <0.05). These include miR-6124 (hazard ratio, 1.66 [95% CI, 1.31–2.09]), miR-5196-5p (hazard ratio, 1.90 [95% CI, 1.39–2.61]), and miR-4292 (hazard ratio, 2.65 [95% CI, 1.62–4.34]). In silico analysis of the putative target genes of these miRNAs showed associations of variants in several target genes with stroke. Conclusions: This study indicates that plasma levels of 3 miRNAs are associated with the risk of stroke, proposing them as potential biomarkers for early detection of the disease.

27 November 2020 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
XZXiaofang Zhang
Xiaofang Zhang
MMMichelle M. J. Mens
Michelle M. J. Mens
YAYasir J. Abozaid
Yasir J. Abozaid
DBDaniel Bos
Daniel Bos
SMSarwa Darwish Murad
Sarwa Darwish Murad
MGMohsen Ghanbari
Mohsen Ghanbari
Summary: Background: Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD.Aim: To investigate the potential of circulatory microRNAs (miRNAs) as biomarkers of FLD at the population level.Methods: Plasma levels of 2083 miRNAs were measured by RNA sequencing in 1999 participants from the prospective population‐based Rotterdam Study cohort. The Hounsfield Unit (HU) attenuation of liver was measured using non‐enhanced computed tomography (CT) scan. Logistic and linear regression models adjusting for potential confounders were used to examine the association of circulatory miRNAs with liver enzymes (n = 1991) and CT‐based FLD (n = 954). Moreover, the association of miRNAs with hepatic steatosis and liver fibrosis was assessed longitudinally in individuals who underwent abdominal ultrasound (n = 1211) and transient elastography (n = 777) after a median follow‐up of >6 years.Results: Cross‐sectional analysis showed 61 miRNAs significantly associated with serum gamma‐glutamyl transferase and/or alkaline phosphatase levels (Bonferroni‐corrected P < 8.46 × 10−5). Moreover, 17 miRNAs were significantly associated with CT‐based FLD (P < 8.46 × 10−5); 14 were among miRNAs associated with liver enzymes. Longitudinal analysis showed that 4 of these 14 miRNAs (miR‐193a‐5p, miR‐122‐5p, miR‐378d and miR‐187‐3p) were significantly associated with hepatic steatosis (P < 3.57 × 10−3) and three (miR‐193a‐5p, miR‐122‐5p and miR‐193b‐3p) were nominally associated with liver fibrosis (P < 0.05). Nine of the 14 identified miRNAs were involved in pathways underlying liver diseases.Conclusions: Plasma levels of several miRNAs can be used as biomarkers of FLD, laying the groundwork for future clinical applications.

22 July 2022 in Journal of Youth and Adolescence
Verified
Journal Article
Open access
PDF file
MMMichelle M. J. Mens
Michelle M. J. Mens
LKLoes Keijsers
Loes Keijsers
EDEvelien Dietvorst
Evelien Dietvorst
SKSoldado Koval
Soldado Koval
JLJeroen S. Legerstee
Jeroen S. Legerstee
MHManon H. J. Hillegers
Manon H. J. Hillegers
Adolescents are at increased risk for developing mental health problems. The Grow It! app is an mHealth intervention aimed at preventing mental health problems through improving coping by cognitive behavioral therapy (CBT)-inspired challenges as well as self-monitoring of emotions through Experience Sampling Methods (ESM). Yet, little is known about daily changes in well-being and coping during a stressful period, like the COVID-19 pandemic. The current study aimed to elucidate daily changes in positive and negative affect, and adaptive coping, and to better understand the within-person’s mechanisms of the Grow It! app. The sample consisted of 12–25-year old Dutch adolescents in two independent cohorts (cohort 1: N = 476, Mage = 16.24, 76.1% female, 88.7% Dutch; cohort 2: N = 814, Mage = 18.45, 82.8% female, 97.2% Dutch). ESM were used to measure daily positive and negative affect and coping (cohort 1: 42 days, 210 assessments per person; cohort 2: 21 days, 105 assessments). The results showed that, on average, adolescents decreased in daily positive affect and adaptive coping, and increased in their experienced negative affect. A positive relation between adaptive coping and positive affect was found, although independent of the CBT-based challenges. Latent class analysis identified two heterogeneous trajectories for both positive and negative affect, indicating that the majority of participants with low to moderate-risk on developing mental health problems were likely to benefit from the Grow It! app.

7 May 2022 in European Child & Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
EDE. Dietvorst
E. Dietvorst
JLJ. S. Legerstee
J. S. Legerstee
AVA. Vreeker
A. Vreeker
SKS. Koval
S. Koval
MMM. M. Mens
M. M. Mens
MHM. H. J. Hillegers
M. H. J. Hillegers
Adolescent mental health and well-being have been adversely impacted by the COVID-19 pandemic. In this preregistered longitudinal study, we evaluated whether adolescents’ well-being improved after playing the multiplayer serious game app Grow It! During the first lockdown (May–June 2020), 1282 Dutch adolescents played the Grow It! app (age = 16.67, SD = 3.07, 68% girls). During the second lockdown (December–May 2020 onwards), an independent cohort of 1871 adolescents participated (age = 18.66, SD = 3.70, 81% girls). Adolescents answered online questionnaires regarding affective and cognitive well-being, depressive symptoms, anxiety, and impact of COVID-19 at baseline. Three to six weeks later, the baseline questionnaire was repeated and user experience questions were asked (N = 462 and N = 733 for the first and second cohort). In both cohorts, affective and cognitive well-being increased after playing the Grow It! app (t = − 6.806, p < 0.001; t = − 6.77, p < 0.001; t = − 6.12, p < 0.001; t = − 5.93, p < 0.001; Cohen’s d range 0.20–0.32). At the individual level, 41–53% of the adolescents increased in their affective or cognitive well-being. Adolescents with higher risk profiles (i.e., more depressive symptoms, lower atmosphere at home, and more COVID-19 impact) improved more strongly in their well-being. Positive user evaluations and app engagement were unrelated to changes in affective and cognitive well-being. This proof-of-concept study tentatively suggests that Grow It! supported adolescents during the pandemic.

17 May 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MMMichelle M.J. Mens
Michelle M.J. Mens
RMRima Mustafa
Rima Mustafa
FAFariba Ahmadizar
Fariba Ahmadizar
MIM. Arfan Ikram
M. Arfan Ikram
MEMarina Evangelou
Marina Evangelou
MGMohsen Ghanbari
Mohsen Ghanbari
MicroRNAs (miRNAs) have emerged as key regulators of gene expression. Differential expression of miRNAs has been linked to diabetes, but underlying pathways remain poorly understood. We performed genome-wide miRNAs profiling and tested the causal associations between miRNAs and type 2 diabetes in the general population. Subsequently, we investigated target genes and metabolites of miRNAs to provide insight into the metabolic disturbances that emerge with type 2 diabetes. Between 2002 and 2005, plasma levels of 2083 circulatory miRNAs were profiled in 1900 participants (mean age 71.4 years) of the population-based Rotterdam Study cohort. The associations of 591 well-expressed miRNAs with prevalent and incident type 2 diabetes were examined until 2015. Two-sample Mendelian Randomization (MR) was conducted to investigate the causal associations and miRNA-target genes and metabolites were studied in relation to type 2 diabetes. At baseline, higher plasma levels of miR-139-5p and miR-193a-5p were associated (FDR9.0 years, 209 participants developed type 2 diabetes. Plasma levels of miR-99a-5p, miR-4664-3p, miR-29a-3p, miR-122-5p, and miR-125b-5p were significantly associated with incident type 2 diabetes (n=209). Two-sample MR confirmed a causal effect for miR-139-5p (MR-IWV-beta=0.10, p=3.51×10 −4 ) on type 2 diabetes. We found several target genes and metabolites that could link miR-139-5p to pathways underlying type 2 diabetes. Our study indicates a causal relationship between miR-139-5p and type 2 diabetes and suggests this miRNA as a plasma biomarker of type 2 diabetes.

7 July 2022 in PsyArXiv
Verified
Preprint
Open access
MMMichelle Mens
Michelle Mens
LKLoes Keijsers
Loes Keijsers
EDEvelien Dietvorst
Evelien Dietvorst
SKSoldado Koval
Soldado Koval
JLJeroen Legerstee
Jeroen Legerstee
MHManon H.J. Hillegers
Manon H.J. Hillegers
Adolescents are at increased risk for developing mental health problems. The Grow It! app is an mHealth intervention aimed at preventing mental health problems through improving coping by cognitive behavioral therapy (CBT)-inspired challenges as well as self-monitoring of emotions through Experience Sampling Methods (ESM). Yet, little is known about daily changes in well-being and coping during a stressful period, like the COVID-19 pandemic. The current study aimed to elucidate daily changes in positive and negative affect, and adaptive coping, and to better understand the within-person’s mechanisms of the Grow It! app. The sample consisted of 12-25-year old Dutch adolescents in two independent cohorts (cohort 1: N = 476, Mage=16.24, 76.1% female, 88.7% Dutch; cohort 2: N = 814, Mage=18.45, 82.8% female, 97.2% Dutch). ESM were used to measure daily positive and negative affect and coping (cohort 1: 42 days, 210 assessments per person; cohort 2: 21 days, 105 assessments). The results showed that, on average, adolescents decreased in daily positive affect and adaptive coping, and increased in their experienced negative affect. A positive relation between adaptive coping and positive affect was found, although independent of the CBT-based challenges. Latent class analysis identified two heterogeneous trajectories for both positive and negative affect, indicating that the majority of participants with low to moderate-risk on developing mental health problems were likely to benefit from the Grow It! app.